What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Tuberculosis
His scientific interests lie mostly in Tuberculosis, Mycobacterium tuberculosis, Isoniazid, Pharmacology and Pyrazinamide.
His Tuberculosis study integrates concerns from other disciplines, such as Regimen, Internal medicine, Single-strand conformation polymorphism and Immunology.
Jacques H. Grosset interconnects In vitro, Antibiotics, Microbiology, Virology and Virulence in the investigation of issues within Mycobacterium tuberculosis.
His Isoniazid study combines topics from a wide range of disciplines, such as Gastroenterology and Multiple drug resistance.
His Pharmacology research integrates issues from Rifapentine, Pharmacotherapy and Rifamycin.
The study incorporates disciplines such as Moxifloxacin, Chemotherapy and SQ109 in addition to Pyrazinamide.
His most cited work include:
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis (485 citations)
- Fluoroquinolones, tuberculosis, and resistance (321 citations)
- A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: Application to Mycobacterium tuberculosis (314 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Tuberculosis, Pharmacology, Mycobacterium tuberculosis, Microbiology and Antibacterial agent.
His studies deal with areas such as Regimen, Internal medicine, Immunology and Clofazimine as well as Tuberculosis.
His research in Pharmacology intersects with topics in Moxifloxacin and Rifapentine.
His Mycobacterium tuberculosis research incorporates themes from In vitro, Mutant, Gene, Lung and Granuloma.
The Microbiology study combines topics in areas such as Guinea pig, Virology, In vivo and Ratón.
His Antibacterial agent research includes themes of Clarithromycin and Rifampicin.
He most often published in these fields:
- Tuberculosis (50.33%)
- Pharmacology (36.42%)
- Mycobacterium tuberculosis (30.46%)
What were the highlights of his more recent work (between 2011-2019)?
- Tuberculosis (50.33%)
- Pharmacology (36.42%)
- Clofazimine (15.23%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Tuberculosis, Pharmacology, Clofazimine, Rifapentine and Regimen.
Jacques H. Grosset is interested in Mycobacterium tuberculosis, which is a field of Tuberculosis.
His Pharmacology research is multidisciplinary, incorporating perspectives in Pyrazinamide, Ethambutol, Isoniazid and Bedaquiline.
His Ethambutol research includes elements of Culture conversion, Moxifloxacin and Clarithromycin.
As a part of the same scientific family, Jacques H. Grosset mostly works in the field of Clofazimine, focusing on Dosing and, on occasion, Combination therapy and Guinea pig.
His Rifapentine study incorporates themes from Rifamycin and TB chemotherapy.
Between 2011 and 2019, his most popular works were:
- Targeting DnaN for tuberculosis therapy using novel griselimycins (168 citations)
- Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis (104 citations)
- New drugs for the treatment of tuberculosis: hope and reality. (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Bacteria
- Antibiotics
His primary areas of investigation include Tuberculosis, Pharmacology, Clofazimine, Ethambutol and Mycobacterium tuberculosis.
His research integrates issues of Gastroenterology and Regimen in his study of Tuberculosis.
Regimen is closely attributed to Pyrazinamide in his study.
His Mycobacterium tuberculosis study combines topics in areas such as Complementation, Mutant, Efflux and Mutation.
His work focuses on many connections between Culture conversion and other disciplines, such as Moxifloxacin, that overlap with his field of interest in Surgery.
The various areas that Jacques H. Grosset examines in his Rifapentine study include Rifamycin and SQ109.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
